Researchers discover how amyloid-β and tau pathologies interact to drive early neurophysiological changes and cognitive ...

Researchers at the University of California, Los Angeles (UCLA) have pioneered a groundbreaking approach in the imaging and ...

Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...

The following is a summary of “Association of vascular risk factors and cerebrovascular pathology with Alzheimer disease ...

Amyloid-beta and tau proteins have long been associated with Alzheimer's disease. The pathological buildup of these proteins ...

GE HealthCare’s recently acquired MIM Software division has secured an FDA clearance for a tool to help quantify the density ...

Patients with MS showed half the rate of amyloid pathology compared with people without MS, suggesting a possible protective ...

Increasingly, researchers are looking to develop blood tests that could help make Alzheimer's diagnosis faster, more accurate ...

In a major discovery, scientists have presented the first evidence of Alzheimer's disease transmission in living individuals.

The approach aims to increase clinician confidence in determining amyloid plaque density - a key signifier of Alzheimer’s ...

With FDA 510(k) clearance, MIMneuro may perform positron emission tomography-based imaging analysis of amyloid plaque, GE ...

Once amyloid pathology is underway, it predicts intracellular accumulation of hyperphosphorylated tau as neurofibrillary tangles and that, in turn, predicts onset of cognitive impairment.